Clinical trial of a prion disease drug candidate begins enrolling participants
“Eric and Sonia are visionaries who are not only top-notch scientists, but have enormous ethical conviction. I’m honored to have an opportunity to work with them,” said Khvorova, professor in UMass’s RNA Therapeutics Institute and Program in Molecular …